procaterol
Also known as SID26752069, SID11113915
Procaterol is a β2 adrenoreceptor agonist used for the treatment of asthma in many countries, but is not approved in the United States. The drug is readily oxidized in the presence of moisture and air, and requires stabilizers for use by inhalation.
Research
503 papers- Procaterol for Infantile Sick Sinus Syndrome.Indian pediatrics · 2019
- Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study.Medical sciences (Basel, Switzerland) · 2025
- Ezrin knockdown reduces procaterol-stimulated ciliary beating without morphological changes in mouse airway cilia.Journal of cell science · 2022
- Cisplatin and Procaterol Combination in Gastric Cancer? Targeting Checkpoint Kinase 1 for Cancer Drug Discovery and Repurposing by an Integrated Computational and Experimental Approach.Omics : a journal of integrative biology · 2024
- Effects of Oral Procaterol for Postinfectious Cough in Adults: Single-Centre, Randomized Double-Blind, Placebo-Controlled Trial.Korean journal of family medicine · 2021
via PubMed
Article
3 sectionsContents
- Synthesis
- Names
- References
Procaterol is a β2 adrenoreceptor agonist used for the treatment of asthma in many countries, but is not approved in the United States. The drug is readily oxidized in the presence of moisture and air, and requires stabilizers for use by inhalation.
It was patented in 1974 and came into medical use in 1980. Procaterol is similar to salbutamol (albuterol), but has a somewhat more prolonged action. It can be taken orally or by inhalation to treat asthma.
Available in 12 languages
Connections
Categories
2-QuinolonesBeta2-adrenergic agonistsBeta-HydroxyamphetaminesChemical articles with multiple CAS registry numbersChemical pages without DrugBank identifierChemicals using indexlabelsDrugboxes which contain changes to verified fieldsDrugs with no legal statusECHA InfoCard ID from WikidataMultiple chemicals in Infobox drugQuinolinols